The PDXK Knockout Raji Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji B lymphocyte cell line, in which the PDXK gene encoding pyridoxal kinase has been disrupted. This knockout model enables the investigation of PDXK function without presupposing a specific editing outcome, as the polyclonal nature captures a spectrum of loss-of-function mutations. By abolishing PDXK-mediated phosphorylation, these cells provide a reliable system to study the consequences of impaired vitamin B6 salvage and pyridoxal 5??-phosphate (PLP) production.
Raji cells are a well-characterized Burkitt lymphoma-derived B lymphocyte line widely used to study B cell biology, antigen presentation, and antibody production. Originating from a B cell malignancy, they retain key features of B lymphocytes, including expression of surface immunoglobulins and capacity for antigen processing. This makes them an ideal host for exploring how metabolic perturbations, such as those induced by PDXK knockout, impact immune cell function and lymphomagenesis.
PDXK encodes pyridoxal kinase, the enzyme responsible for phosphorylating vitamin B6 vitamers??pyridoxal, pyridoxamine, and pyridoxine??into pyridoxal 5??-phosphate (PLP), the active cofactor. PLP serves as an essential coenzyme for numerous enzymes including glutamate decarboxylase (GAD), aromatic L-amino acid decarboxylase (AADC), serine hydroxymethyltransferase (SHMT), cystathionine ??-synthase (CBS), and various transaminases, thereby linking PDXK activity to amino acid metabolism, neurotransmitter biosynthesis, and one-carbon metabolism. The kinase requires ATP as a co-substrate and is putatively regulated by intracellular PLP levels. Knockout of PDXK disrupts this cascade, leading to PLP deficiency and inactivation of downstream PLP-dependent enzymes.
In the context of Raji B lymphocytes, PDXK knockout likely disturbs PLP-dependent processes critical for cellular proliferation, metabolism, and specialized immune functions. Given PLP??s role in transamination and decarboxylation reactions, impaired PDXK may alter amino acid utilization, impact energy metabolism, and possibly modulate antibody synthesis or antigen presentation. Dysregulation of vitamin B6 metabolism has been implicated in cancer, with some tumors exhibiting altered PDXK expression. Thus, this knockout model provides a valuable tool to dissect the metabolic requirements of B cell malignancies and explore PDXK as a therapeutic target.
Researchers can employ these PDXK Knockout Raji Polyclonal Cells in various experimental paradigms. Common applications include metabolic profiling via HPLC-based quantitation of PLP and B6 vitamers, enzymatic activity assays for PLP-dependent enzymes, western blotting to confirm PDXK ablation, RT-qPCR analysis of PDXK mRNA, and proliferation assays to assess growth dependency on vitamin B6 salvage. The model is well-suited for drug target validation in B-cell cancer and for investigating the intersection of vitamin B6 metabolism with immune cell function. For further information, please contact Ascent Research.
